These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 626198)

  • 21. Cumulative sum control charts for admixture quality control.
    Sanford RL
    Am J Hosp Pharm; 1980 May; 37(5):655-9. PubMed ID: 7386472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
    Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
    Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compounding TPN admixtures: then and now.
    Driscoll DF
    JPEN J Parenter Enteral Nutr; 2003; 27(6):433-8; quiz 439. PubMed ID: 14621126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost of wastage in a hospital intravenous admixture program.
    Salberg DJ; Newton RW; Leduc DT
    Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qaulity-control plan for intravenous admixture programs. II: Validation of operator technique.
    Morris BG; Avis KE; Bowles GC
    Am J Hosp Pharm; 1980 May; 37(5):668-72. PubMed ID: 7386475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outsourcing inpatient i.v. compounding: expense and medication error implications.
    Burruss RA; Carroll NV; Schraa C; Burton B
    Pharm Pract Manag Q; 1996 Oct; 16(3):52-9. PubMed ID: 10166235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The application of a freeze-microwave thaw technique to central admixture services.
    Ausman RK; Holmes CJ; Walter CW; Kundsin RB
    Drug Intell Clin Pharm; 1980 Apr; 14(4):284-7. PubMed ID: 10247135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of quality assurance in hospital pharmacy.
    Oakley RS; Bradham DD
    Am J Hosp Pharm; 1983 Jan; 40(1):53-63. PubMed ID: 6823989
    [No Abstract]   [Full Text] [Related]  

  • 30. A feasibility study of a decentralized unit dose and intravenous admixture system in a large cancer center.
    Hoffman DM
    Hosp Pharm; 1977 Apr; 12(4):163-5, 168-70. PubMed ID: 10305439
    [No Abstract]   [Full Text] [Related]  

  • 31. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating aseptic technique of pharmacy personnel.
    Brier KL
    Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
    Hecq JD
    Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 36. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive intravenous admixture services: logistics and quality assurance in a university affiliated teaching institution.
    Wellman GS; Hale KM; Schneider PJ; Hale KN
    Hosp Pharm; 1984 Sep; 19(9):601-6. PubMed ID: 10267935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Justification of a pharmacy intravenous admixture service in an Australian hospital.
    Plumridge RJ; Maher M
    Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 40. Panel discussion: hospital intravenous additive programs. I. An analysis of a hospital's I.V. additive service.
    Schwarz MA
    Bull Parenter Drug Assoc; 1969; 23(2):78-80. PubMed ID: 5776422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.